Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Animal Sedative Market, by Route of Administration
1.4.2 North America Animal Sedative Market, by Animal Type
1.4.3 North America Animal Sedative Market, by Drug Class
1.4.4 North America Animal Sedative Market, by End Use
1.4.5 North America Animal Sedative Market, by Application
1.4.6 North America Animal Sedative Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. North America Animal Sedative Market by Route of Administration
4.1 North America Parenteral Market by Region
4.2 North America Oral Market by Region
Chapter 5. North America Animal Sedative Market by Animal Type
5.1 North America Dogs Market by Country
5.2 North America Cats Market by Country
5.3 North America Horses Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Animal Sedative Market by Drug Class
6.1 North America Alpha-2 Adrenergic Receptor Agonists Market by Country
6.2 North America Phenothiazines Market by Country
6.3 North America Benzodiazepines Market by Country
6.4 North America Butyrophenones Market by Country
6.5 North America Others Market by Country
Chapter 7. North America Animal Sedative Market by End Use
7.1 North America Hospitals Market by Country
7.2 North America Specialty Centers Market by Country
Chapter 8. North America Animal Sedative Market by Application
8.1 North America Surgical Market by Country
8.2 North America Diagnostic Market by Country
8.3 North America Others Market by Country
Chapter 9. North America Animal Sedative Market by Country
9.1 US Animal Sedative Market
9.1.1 US Animal Sedative Market by Route of Administration
9.1.2 US Animal Sedative Market by Animal Type
9.1.3 US Animal Sedative Market by Drug Class
9.1.4 US Animal Sedative Market by End Use
9.1.5 US Animal Sedative Market by Application
9.2 Canada Animal Sedative Market
9.2.1 Canada Animal Sedative Market by Route of Administration
9.2.2 Canada Animal Sedative Market by Animal Type
9.2.3 Canada Animal Sedative Market by Drug Class
9.2.4 Canada Animal Sedative Market by End Use
9.2.5 Canada Animal Sedative Market by Application
9.3 Mexico Animal Sedative Market
9.3.1 Mexico Animal Sedative Market by Route of Administration
9.3.2 Mexico Animal Sedative Market by Animal Type
9.3.3 Mexico Animal Sedative Market by Drug Class
9.3.4 Mexico Animal Sedative Market by End Use
9.3.5 Mexico Animal Sedative Market by Application
9.4 Rest of North America Animal Sedative Market
9.4.1 Rest of North America Animal Sedative Market by Route of Administration
9.4.2 Rest of North America Animal Sedative Market by Animal Type
9.4.3 Rest of North America Animal Sedative Market by Drug Class
9.4.4 Rest of North America Animal Sedative Market by End Use
9.4.5 Rest of North America Animal Sedative Market by Application
Chapter 10. Company Profiles
10.1 Zoetis, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.6 SWOT Analysis
10.2 Virbac
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Product Launches and Product Expansions:
10.2.5 SWOT Analysis
10.3 Dechra Pharmaceuticals PLC
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental & Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Merck & Co., Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 SWOT Analysis
10.5 Bimeda, Inc.
10.5.1 Company Overview
10.5.2 Recent strategies and developments:
10.5.2.1 Product Launches and Product Expansions:
10.5.3 SWOT Analysis
10.6 Ouro Fino Saude Animal Participacoes S.A.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expenses
10.7 vetcare. fi.
10.7.1 Company Overview
10.8 Chanelle Pharma (Exponent)
10.8.1 Company Overview
10.9 Randlab Australia Pty Ltd.
10.9.1 Company Overview
10.10. Troy Laboratories Pty Ltd.
10.10.1 Company Overview
Unique Offerings 